<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Publications on Agnès Pérez-Millan</title>
    <link>https://Agnes2.github.io/publications/</link>
    <description>Recent content in Publications on Agnès Pérez-Millan</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 07 Jan 2020 16:47:30 +0000</lastBuildDate><atom:link href="https://Agnes2.github.io/publications/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Beyond group classification: Probabilistic differential diagnosis of frontotemporal dementia and Alzheimer’s disease with MRI and CSF biomarkers</title>
      <link>https://Agnes2.github.io/publications/2024-probabilities/</link>
      <pubDate>Fri, 30 Aug 2024 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2024-probabilities/</guid>
      <description>Agnès Pérez-Millan, Bertrand Thirion, Neus Falgàs, Sergi Borrego-Écija, Beatriz Bosch, Jordi Juncà-Parella, Adrià Tort-Merino, Jordi Sarto, Josep Maria Augé, Anna Antonell, Nuria Bargalló, Mircea Balasa, Albert Lladó, Raquel Sánchez-Valle, Roser Sala-Llonch. Neurobiology of Aging.
ABSTRACT
Neuroimaging and fluid biomarkers are used to differentiate frontotemporal dementia (FTD) from Alzheimer’s disease (AD). We implemented a machine learning algorithm that provides individual probabilistic scores based on magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) data.</description>
    </item>
    
    <item>
      <title>Locus coeruleus integrity and neuropsychiatric symptoms in a cohort of early-and late-onset Alzheimer’s disease</title>
      <link>https://Agnes2.github.io/publications/2024-locus/</link>
      <pubDate>Thu, 25 Jul 2024 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2024-locus/</guid>
      <description>Neus Falgàs, Marta Peña-González, Andrea Val-Guardiola, Agnès Pérez-Millan, Núria Guillén, Jordi Sarto, Diana Esteller, Beatriz Bosch, Guadalupe Fernández-Villullas, Adrià Tort-Merino, Gerard Mayà, Josep Maria Augé, Alex Iranzo, Mircea Balasa, Albert Lladó, Manuel Morales-Ruiz, Núria Bargalló, Emma Muñoz-Moreno, Lea T Grinberg, Raquel Sánchez-Valle. Alzheimer&amp;rsquo;s &amp;amp; Dementia.
ABSTRACT
INTRODUCTION Early-onset Alzheimer&amp;rsquo;s disease (EOAD) shows a higher burden of neuropsychiatric symptoms than late-onset Alzheimer&amp;rsquo;s disease (LOAD). We aim to determine the differences in the severity of neuropsychiatric symptoms and locus coeruleus (LC) integrity between EOAD and LOAD accounting for disease stage.</description>
    </item>
    
    <item>
      <title>Increase in wasteosomes (corpora amylacea) in frontotemporal lobar degeneration with specific detection of tau, TDP-43 and FUS pathology</title>
      <link>https://Agnes2.github.io/publications/2024-watesomes/</link>
      <pubDate>Sat, 15 Jun 2024 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2024-watesomes/</guid>
      <description>Raquel Alsina, Marta Riba, Agnès Pérez-Millan, Sergi Borrego-Écija, Iban Aldecoa, Clara Romera, Mircea Balasa, Anna Antonell, Albert Lladó, Yaroslau Compta, Jaume Del Valle, Raquel Sánchez-Valle, Carme Pelegrí, Laura Molina-Porcel, Jordi Vilaplana. Acta Neuropathologica Communications
ABSTRACT
Wasteosomes (or corpora amylacea) are polyglucosan bodies that appear in the human brain with aging and in some neurodegenerative diseases, and have been suggested to have a potential role in a nervous system cleaning mechanism. Despite previous studies in several neurodegenerative disorders, their status in frontotemporal lobar degeneration (FTLD) remains unexplored.</description>
    </item>
    
    <item>
      <title>Cognitive profile, neuroimaging and fluid biomarkers in post-acute COVID-19 syndrome</title>
      <link>https://Agnes2.github.io/publications/2024-covid/</link>
      <pubDate>Wed, 05 Jun 2024 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2024-covid/</guid>
      <description>Núria Guillén*, Agnès Pérez-Millan*, Neus Falgàs, Gema M Lledó-Ibáñez, Lorena Rami, Jordi Sarto, Maria A Botí, Cristina Arnaldos-Pérez, Raquel Ruiz-García, Laura Naranjo, Bàrbara Segura, Mircea Balasa, Roser Sala-Llonch, Albert Lladó, Sarah M Gray, Jason K Johannesen, Madeline M Pantoni, Grant A Rutledge, Ruta Sawant, Yi Wang, Luke S Watson, Josep Dalmau, Raquel Sánchez‐Valle. (* equivalent contribution). Scientific Reports.
ABSTRACT
We aimed to characterize the cognitive profile of post-acute COVID-19 syndrome (PACS) patients with cognitive complaints, exploring the influence of biological and psychological factors.</description>
    </item>
    
    <item>
      <title>Impact of demographics and comorbid conditions on plasma biomarkers concentrations and their diagnostic accuracy in a memory clinic cohort</title>
      <link>https://Agnes2.github.io/publications/2024-plasma/</link>
      <pubDate>Mon, 01 Apr 2024 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2024-plasma/</guid>
      <description>Jordi Sarto, Diana Esteller-Gauxax, Adrià Tort-Merino, Núria Guillén, Agnès Pérez‐Millan, Neus Falgàs, Sergi Borrego-Écija, Guadalupe Fernández-Villullas, Beatriz Bosch, Jordi Juncà-Parella, Anna Antonell, Laura Naranjo, Raquel Ruiz-García, Josep María Augé, Raquel Sánchez-Valle, Albert Lladó, Mircea Balasa. Journal of Neurology.
ABSTRACT
Plasma biomarkers have emerged as promising tools for identifying amyloid beta (Aβ) pathology. Before implementation in routine clinical practice, confounding factors modifying their concentration beyond neurodegenerative diseases should be identified. We studied the association of a comprehensive list of demographics, comorbidities, medication and laboratory parameters with plasma p-tau181, glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) on a prospective memory clinic cohort and studied their impact on diagnostic accuracy for discriminating CSF/amyloid PET-defined Aβ status.</description>
    </item>
    
    <item>
      <title>Cortical thickness modeling and variability in Alzheimer’s disease and frontotemporal dementia</title>
      <link>https://Agnes2.github.io/publications/2024-cth/</link>
      <pubDate>Fri, 01 Mar 2024 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2024-cth/</guid>
      <description>Agnès Pérez‐Millan, Sergi Borrego-Écija, Neus Falgàs, Jordi Juncà-Parella, Beatriz Bosch, Adrià Tort-Merino, Anna Antonell, Nuria Bargalló, Lorena Rami, Mircea Balasa, Albert Lladó, Roser Sala-Llonch, Raquel Sánchez-Valle. Journal of Neurology.
ABSTRACT
Background and objective Alzheimer’s disease (AD) and frontotemporal dementia (FTD) show different patterns of cortical thickness (CTh) loss compared with healthy controls (HC), even though there is relevant heterogeneity between individuals suffering from each of these diseases. Thus, we developed CTh models to study individual variability in AD, FTD, and HC.</description>
    </item>
    
    <item>
      <title>Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity</title>
      <link>https://Agnes2.github.io/publications/2024-gal3/</link>
      <pubDate>Fri, 01 Mar 2024 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2024-gal3/</guid>
      <description>Sergi Borrego-Écija*, Agnès Pérez-Millan*, Anna Antonell, Laura Fort-Aznar, Elif Kaya-Tilki, Alberto León-Halcón, Albert Lladó, Laura Molina-Porcel, Mircea Balasa, Jordi Juncà-Parella, Javier Vitorica, Jose Luis Venero, Tomas Deierborg, Antonio Boza-Serrano, Raquel Sánchez-Valle. (* equivalent contribution). Alzheimer&amp;rsquo;s &amp;amp; Dementia.
ABSTRACT
INTRODUCTION Neuroinflammation is a major contributor to the progression of frontotemporal dementia (FTD). Galectin-3 (Gal-3), a microglial activation regulator, holds promise as a therapeutic target and potential biomarker. Our study aimed to investigate Gal-3 levels in patients with FTD and assess its diagnostic potential.</description>
    </item>
    
    <item>
      <title>Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study</title>
      <link>https://Agnes2.github.io/publications/2022-c9/</link>
      <pubDate>Wed, 01 Mar 2023 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2022-c9/</guid>
      <description>Agnès Pérez-Millan*, Sergi Borrego-Écija*, John C van Swieten, Lize Jiskoot, Fermin Moreno, Robert Laforce, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James B Rowe, Barbara Borroni, Elizabeth Finger, Matthis Synofzik, Daniela Galimberti, Rik Vandenberghe, Alexandre de Mendonça, Chris R Butler, Alexander Gerhard, Simon Ducharme, Isabelle Le Ber, Isabel Santana, Florence Pasquier, Johannes Levin, Markus Otto, Sandro Sorbi, Pietro Tiraboschi, Harro Seelaar, Tobias Langheinrich, Jonathan D Rohrer, Roser Sala-Llonch, Raquel Sánchez-Valle &amp;amp; The Genetic FTD Initiative, GENFI (* equivalent contribution).</description>
    </item>
    
    <item>
      <title>The APOE4 effect: structural brain differences in Alzheimer’s disease according to the age at symptom onset</title>
      <link>https://Agnes2.github.io/publications/2022-apope/</link>
      <pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2022-apope/</guid>
      <description>Gonzalo Forno, Jose Contador, Agnès Pérez‐Millan, Nuria Guillen, Neus Falgàs, Jordi Sarto, Adrià Tort‐Merino, Magdalena Castellví, Beatriz Bosch, Guadalupe Fernández‐Villullas, Mircea Balasa, Anna Antonell, Roser Sala‐Llonch, Raquel Sanchez‐Valle, Michael Hornberger, Albert Lladó. European Journal of Neurology.
ABSTRACT
Background and purpose: How the APOE genotype can differentially affect cortical and subcortical memory structures in biomarker-confirmed early-onset (EOAD) and late-onset (LOAD) Alzheimer&amp;rsquo;s disease (AD) was assessed.
Method: Eighty-seven cerebrospinal fluid (CSF) biomarker-confirmed AD patients were classified according to their APOE genotype and age at onset.</description>
    </item>
    
    <item>
      <title>Design and validation of the 1-week memory battery for assessing episodic memory and accelerated long-term forgetting in cognitively unimpaired subjects.</title>
      <link>https://Agnes2.github.io/publications/2023-neuropsico/</link>
      <pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2023-neuropsico/</guid>
      <description>Lorena Rami, María León, Natalia Valech, Nina Coll-Padrós, Beatriz Bosch, Jaume Olives, Ana Salinero, Agnès Pérez-Millan, José Luis Molinuevo, Raquel Sánchez-Valle, Adrià Tort-Merino. Neuropsychology.
ABSTRACT
Objective: Subtle decline in memory is thought to arise in the preclinical phase of Alzheimer’s disease (AD). However, detecting these initial cognitive difficulties cross-sectionally has been challenging, and the exact nature of the decline is still debated. Accelerated long-term forgetting (ALF) has been recently suggested as one of the earliest and most sensitive indicators of memory dysfunction in subjects at risk of developing AD.</description>
    </item>
    
    <item>
      <title>Classifying Alzheimer’s disease and frontotemporal dementia using machine learning with cross‐sectional and longitudinal magnetic resonance imaging data</title>
      <link>https://Agnes2.github.io/publications/2023-mllong/</link>
      <pubDate>Wed, 04 Jan 2023 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2023-mllong/</guid>
      <description>Agnès Pérez‐Millan, José Contador, Jordi Juncà‐Parella, Beatriz Bosch, Laia Borrell, Adrià Tort‐Merino, Neus Falgàs, Sergi Borrego‐Écija, Nuria Bargalló, Lorena Rami, Mircea Balasa, Albert Lladó, Raquel Sánchez‐Valle, Roser Sala‐Llonch. Human Brain Mapping.
ABSTRACT
Alzheimer&amp;rsquo;s disease (AD) and frontotemporal dementia (FTD) are common causes of dementia with partly overlapping, symptoms and brain signatures. There is a need to establish an accurate diagnosis and to obtain markers for disease tracking. We combined unsupervised and supervised machine learning to discriminate between AD and FTD using brain magnetic resonance imaging (MRI).</description>
    </item>
    
    <item>
      <title>Sex differences in early-onset Alzheimer’s disease</title>
      <link>https://Agnes2.github.io/publications/2022-sex/</link>
      <pubDate>Wed, 02 Nov 2022 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2022-sex/</guid>
      <description>José Contador*, Agnès Pérez-Millan*, Nuria Guillen, Jordi Sarto, Adrià Tort-Merino, Mircea Balasa, Neus Falgàs, Magdalena Castellví, Sergi Borrego-Écija, Jordi Juncà-Parella, Beatriz Bosch, Guadalupe Fernández-Villullas, Oscar Ramos-Campoy, Anna Antonell, Nuria Bargalló, Raquel Sanchez-Valle, Roser Sala Llonch, Albert Lladó (* equivalent contribution). European Journal of Neurology.
ABSTRACT
INTRODUCTION: Sex is believed to drive heterogeneity in Alzheimer’s disease (AD), although evidence in early-onset AD (&amp;lt;65 years, EOAD) is scarce.
METHODS: We included 62 EOAD patients and 44 healthy controls (HC) with cerebrospinal fluid (CSF) AD’s core biomarkers and neurofilament light chain levels, neuropsychological assessment, and 3T-MRI.</description>
    </item>
    
    <item>
      <title>Classification between early onset Alzheimer´s disease and frontotemporal dementia using a single neuroimaging feature</title>
      <link>https://Agnes2.github.io/publications/2022-etaiml/</link>
      <pubDate>Mon, 03 Oct 2022 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2022-etaiml/</guid>
      <description>Agnès Pérez Millan, Laia Borrell, José Contador, Mircea Balasa, Albert Lladó, Raquel Sanchez-Valle, Roser Sala-Llonch. Emerging Topics in Artificial Intelligence (ETAI) 2022.
ABSTRACT
INTRODUCTION: Early Onset Alzheimer’s Disease (EOAD, &amp;lt;65 years) and Frontotemporal Dementia (FTD) are common forms of early-onset dementia. Therefore, there is a need to establish accurate diagnosis and to obtain markers for disease tracking. We combined supervised and unsupervised machine learning (ML) to discriminate between EOAD and FTD patients.</description>
    </item>
    
    <item>
      <title>Differential Gene Expression in Sporadic and Genetic Forms of Alzheimer’s Disease and Frontotemporal Dementia in Brain Tissue and Lymphoblastoid Cell Lines</title>
      <link>https://Agnes2.github.io/publications/2022-gens/</link>
      <pubDate>Sat, 01 Oct 2022 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2022-gens/</guid>
      <description>Oscar Ramos-Campoy, Albert Lladó, Beatriz Bosch, Mireia Ferrer, Agnès Pérez-Millan, Miguel Vergara, Laura Molina-Porcel, Laura Fort-Aznar, Ricardo Gonzalo, Fermín Moreno-Izco, Guadalupe Fernandez-Villullas, Mircea Balasa, Raquel Sánchez-Valle, Anna Antonell. Molecular Neurobiology.
ABSTRACT
Sporadic early-onset Alzheimer’s disease (EOAD) and autosomal dominant Alzheimer’s disease (ADAD) provide the opportunity to investigate the physiopathological mechanisms in the absence of aging, present in late-onset forms. Frontotemporal dementia (FTD) causes early-onset dementia associated to tau or TDP43 protein deposits.</description>
    </item>
    
    <item>
      <title>Evaluating the performance of Bayesian and frequentist approaches for longitudinal modeling: application to Alzheimer’s disease</title>
      <link>https://Agnes2.github.io/publications/2022-bayvsfreq/</link>
      <pubDate>Wed, 24 Aug 2022 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2022-bayvsfreq/</guid>
      <description>Agnès Pérez‐Millan, José Contador, Raúl Tudela, Aida Niñerola-Baizán, Xavier Setoain, Albert Lladó, Raquel Sánchez-Valle, Roser Sala-Llonch, for the Alzheimer&amp;rsquo;s Disease Neuroimaging Initiative. Scientific Reports.
ABSTRACT
Linear mixed effects (LME) modelling under both frequentist and Bayesian frameworks can be used to study longitudinal trajectories. We studied the performance of both frameworks on different dataset configurations using hippocampal volumes from longitudinal MRI data across groups—healthy controls (HC), mild cognitive impairment (MCI) and Alzheimer’s disease (AD) patients, including subjects that converted from MCI to AD.</description>
    </item>
    
    <item>
      <title>Baseline MRI atrophy predicts 2-year cognitive outcomes in early-onset Alzheimer’s disease</title>
      <link>https://Agnes2.github.io/publications/2021-baselineeoad/</link>
      <pubDate>Sun, 01 May 2022 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2021-baselineeoad/</guid>
      <description>José Contador, Agnès Pérez-Millan, Nuria Guillen, Adrià Tort-Merino, Mircea Balasa, Neus Falgàs, Jaume Olives, Magdalena Castellví, Sergi Borrego-Écija, Beatriz Bosch, Guadalupe Fernández-Villullas, Oscar Ramos-Campoy, Anna Antonell, Nuria Bargalló, Raquel Sanchez-Valle, Roser Sala-Llonch, Albert Lladó. Journal of Neurology.
ABSTRACT
Background: MRI atrophy predicts cognitive status in AD. However, this relationship has not been investigated in early-onset AD (EOAD, &amp;lt; 65 years) patients with a biomarker-based diagnosis.
Methods: Forty eight EOAD (MMSE ≥ 15; A + T + N +) and forty two age-matched healthy controls (HC; A − T − N −) from a prospective cohort underwent full neuropsychological assessment, 3T-MRI scan and lumbar puncture at baseline.</description>
    </item>
    
    <item>
      <title>Statistical modelling of compromised longitudinal neuroimaging datasets: an application to alzheimer’s disease</title>
      <link>https://Agnes2.github.io/publications/2021-bayvsfreq-etai/</link>
      <pubDate>Thu, 02 Sep 2021 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2021-bayvsfreq-etai/</guid>
      <description>Agnès Pérez Millan, José Contador, Aida Niñerola-Baizán, Raúl Tudela, Xavier Setoain, Albert Lladó, Raquel Sanchez-Valle, Roser Sala-Llonch, for the Alzheimer&amp;rsquo;s Disease Neuroimaging Initiative. Emerging Topics in Artificial Intelligence (ETAI) 2021.
ABSTRACT
Large datasets of longitudinal data, made available for the neuroimage community, offer the possibility to study trajectories of biomarkers throughout the course of the diseases. For such modelling, approaches emerging from both the frequentist and the Bayesian frameworks have been suggested.</description>
    </item>
    
    <item>
      <title>Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease</title>
      <link>https://Agnes2.github.io/publications/2021-longitudinaleoad/</link>
      <pubDate>Mon, 30 Aug 2021 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2021-longitudinaleoad/</guid>
      <description>José Contador, Agnès Pérez-Millán, Adrià Tort-Merino, Mircea Balasa, Neus Falgàs, Jaume Olives, Magdalena Castellví, Sergi Borrego-Écija, Beatriz Bosch, Guadalupe Fernández-Villullas, Oscar Ramos-Campoy, Anna Antonell, Nuria Bargalló, Raquel Sanchez-Valle, Roser Sala-Llonch, Albert Lladó, Alzheimer&amp;rsquo;s Disease Neuroimaging Initiative. NeuroImage: Clinical.
ABSTRACT
There is evidence of longitudinal atrophy in posterior brain areas in early-onset Alzheimer’s disease (EOAD; aged &amp;lt; 65 years), but no studies have been conducted in an EOAD cohort with fluid biomarkers characterization.</description>
    </item>
    
    <item>
      <title>Contribution of CSF biomarkers to early-onset Alzheimer’s disease and frontotemporal dementia neuroimaging signatures</title>
      <link>https://Agnes2.github.io/publications/2020-ohbm/</link>
      <pubDate>Mon, 06 Jan 2020 00:00:00 +0000</pubDate>
      
      <guid>https://Agnes2.github.io/publications/2020-ohbm/</guid>
      <description>Neus Falgàs, Mariona Ruiz‐Peris, Agnès Pérez‐Millan, Roser Sala‐Llonch, Anna Antonell, Mircea Balasa, Sergi Borrego‐Écija, Oscar Ramos‐Campoy, Josep Maria Augé, Magdalena Castellví, Adrià Tort‐Merino, Jaume Olives, Guadalupe Fernández‐Villullas, Kaj Blennow, Henrik Zetterberg, Núria Bargalló, Albert Lladó, Raquel Sánchez‐Valle. Human Brain Mapping.
ABSTRACT
Prior studies have described distinct patterns of brain gray matter and white matter alterations in Alzheimer&amp;rsquo;s disease (AD) and frontotemporal lobar degeneration (FTLD), as well as differences in their cerebrospinal fluid (CSF) biomarkers profiles.</description>
    </item>
    
  </channel>
</rss>
